295 related articles for article (PubMed ID: 24604919)
1. Two cases of olfactory reference syndrome responding to an atypical antipsychotic and SSRI.
Michael S; Boulton M; Andrews G
Aust N Z J Psychiatry; 2014 Sep; 48(9):878-9. PubMed ID: 24604919
[No Abstract] [Full Text] [Related]
2. Rapid responses of high-dose combined therapy of escitalopram and aripiprazole in a case of severe obsessive compulsive disorder with delusion.
Hou YC; Lai CH
J Neuropsychiatry Clin Neurosci; 2014 Apr; 26(2):E44-5. PubMed ID: 24763791
[No Abstract] [Full Text] [Related]
3. Aripiprazole augmentation in 13 patients with refractory obsessive-compulsive disorder: a case series.
Higuma H; Kanehisa M; Maruyama Y; Ishitobi Y; Tanaka Y; Tsuru J; Hanada H; Kodama K; Isogawa K; Akiyoshi J
World J Biol Psychiatry; 2012 Jan; 13(1):14-21. PubMed ID: 22256827
[TBL] [Abstract][Full Text] [Related]
4. The comparison of aripiprazole and risperidone augmentation in selective serotonin reuptake inhibitor-refractory obsessive-compulsive disorder: a single-blind, randomised study.
Selvi Y; Atli A; Aydin A; Besiroglu L; Ozdemir P; Ozdemir O
Hum Psychopharmacol; 2011 Jan; 26(1):51-7. PubMed ID: 21308781
[TBL] [Abstract][Full Text] [Related]
5. Complex visual hallucinations and delusional infestation comorbidity.
Rocha FL; Caramelli P; Oliveira LC
Arq Neuropsiquiatr; 2012 Jul; 70(7):553-4. PubMed ID: 22836466
[No Abstract] [Full Text] [Related]
6. An olfactory reference syndrome successfully treated by aripiprazole augmentation of antidepressant therapy.
Muffatti R; Scarone S; Gambini O
Cogn Behav Neurol; 2008 Dec; 21(4):258-60. PubMed ID: 19057178
[TBL] [Abstract][Full Text] [Related]
7. Micturition difficulty and urinary retention associated with aripiprazole and citalopram treatment in a male adolescent with Asperger syndrome.
Yalcin O
J Child Adolesc Psychopharmacol; 2014 Dec; 24(10):598-9. PubMed ID: 24511913
[No Abstract] [Full Text] [Related]
8. Antipsychotic augmentation of selective serotonin reuptake inhibitors in resistant tic-related obsessive-compulsive disorder in children and adolescents: a naturalistic comparative study.
Masi G; Pfanner C; Brovedani P
J Psychiatr Res; 2013 Aug; 47(8):1007-12. PubMed ID: 23664673
[TBL] [Abstract][Full Text] [Related]
9. Low-dose aripiprazole in the treatment of SSRI-induced bruxism.
Oulis P; Dimitrakopoulos S; Konstantakopoulos G; Tsaltas E; Kollias K
J Neuropsychiatry Clin Neurosci; 2012; 24(3):E39. PubMed ID: 23037677
[No Abstract] [Full Text] [Related]
10. Aripiprazole augmentation of clomipramine-refractory obsessive-compulsive disorder.
Friedman S; Abdallah TA; Oumaya M; Rouillon F; Guelfi JD
J Clin Psychiatry; 2007 Jun; 68(6):972-3. PubMed ID: 17592930
[No Abstract] [Full Text] [Related]
11. Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis.
Veale D; Miles S; Smallcombe N; Ghezai H; Goldacre B; Hodsoll J
BMC Psychiatry; 2014 Nov; 14():317. PubMed ID: 25432131
[TBL] [Abstract][Full Text] [Related]
12. Effect of aripiprazole augmentation for treatment-resistant somatoform disorder: a case series.
Nagoshi Y; Tominaga T; Fukui K
J Clin Psychopharmacol; 2014 Jun; 34(3):397-8. PubMed ID: 24525655
[No Abstract] [Full Text] [Related]
13. Effect of a serotonin reuptake inhibitor on irritability, apathy, and psychotic symptoms in patients with Alzheimer's disease.
Siddique H; Hynan LS; Weiner MF
J Clin Psychiatry; 2009 Jun; 70(6):915-8. PubMed ID: 19422762
[TBL] [Abstract][Full Text] [Related]
14. Remission of chronic severe selective serotonin-reuptake inhibitor/selective norepinephrine-reuptake inhibitor refractory depression following adjunctive aripiprazole.
Sokolski KN; Gripeos D
Ann Pharmacother; 2008 Sep; 42(9):1348-9. PubMed ID: 18682539
[No Abstract] [Full Text] [Related]
15. Adjunctive citalopram is effective on hallucinations and depersonalization symptoms: a case report.
Di Michele V; Bolino F
Eur Psychiatry; 2004 May; 19(3):185. PubMed ID: 15158931
[No Abstract] [Full Text] [Related]
16. [Delusional parasitosis associated with dialysis treated with aripiprazole].
Duarte C; Choi KM; Li CL
Acta Med Port; 2011; 24(3):457-62. PubMed ID: 22015035
[TBL] [Abstract][Full Text] [Related]
17. Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder.
Papakostas GI; Petersen TJ; Kinrys G; Burns AM; Worthington JJ; Alpert JE; Fava M; Nierenberg AA
J Clin Psychiatry; 2005 Oct; 66(10):1326-30. PubMed ID: 16259548
[TBL] [Abstract][Full Text] [Related]
18. A case series of aripiprazole augmentation of selective serotonin reuptake inhibitors in treatment-refractory obsessive compulsive disorder.
Matsunaga H; Hayashida K; Maebayashi K; Mito H; Kiriike N
Int J Psychiatry Clin Pract; 2011 Nov; 15(4):263-9. PubMed ID: 22121999
[TBL] [Abstract][Full Text] [Related]
19. Aripiprazole augmentation for a patient with partial remission of panic disorder.
Harada T; Yamada K; Sakamoto K; Ishigooka J
J Clin Psychopharmacol; 2009 Jun; 29(3):301-2. PubMed ID: 19440089
[No Abstract] [Full Text] [Related]
20. Olfactory reference syndrome.
Bizamcer AN; Dubin WR; Hayburn B
Psychosomatics; 2008; 49(1):77-81. PubMed ID: 18212181
[No Abstract] [Full Text] [Related]
[Next] [New Search]
